On Invalid Date, Dare Bioscience (NASDAQ: DARE) reported Q3 2022 earnings per share (EPS) of -$0.08, up 55.56% year over year. Total Dare Bioscience earnings for the quarter were -$7.02 million. In the same quarter last year, Dare Bioscience's earnings per share (EPS) was -$0.18.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.